Atlas Trials

A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan

Clinical trial NCT02387138 · COMPLETED

Trial details

NCT number
NCT02387138
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Digestive Cancer
Start date
2014-04-01
Primary completion
2018-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.